COMPARATIVE ASPECTS OF PLACENTAL DYSFUNCTION IN WOMEN USING DIFFERENT METHODS OF CONTRACEPTION IN ANAMNESIS by Lubkovska, Oleksandra
Original Research Article:
full paper




and adolescents. Journal of Pediatric Endocrinology and Metabolism, 32 (10), 1163–1170. doi: http://doi.org/10.1515/
jpem-2019-0037 
[20] Neuman, M. G., Cohen, L. B., Nanau, R. M. (2014). Biomarkers in Nonalcoholic Fatty Liver Disease. Canadian Journal of 
Gastroenterology and Hepatology, 28 (11), 607–618. doi: http://doi.org/10.1155/2014/757929 
[21] He, L., Deng, L., Zhang, Q., Guo, J., Zhou, J., Song, W., Yuan, F. (2017). Diagnostic Value of CK-18, FGF-21, and Related Bio-
marker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. BioMed Research International, 
2017, 1–12. doi: http://doi.org/10.1155/2017/9729107 
[22] Fitzpatrick, E., Mitry, R. R., Quaglia, A., Hussain, M. J., deBruyne, R., Dhawan, A. (2010). Serum Levels of CK18 M30 and 
Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLD. Journal of Pediatric Gastroenterology and 
Nutrition, 51 (4), 500–506. doi: http://doi.org/10.1097/mpg.0b013e3181e376be 
[23] Lebensztejn, D. M., Wierzbicka, A., Socha, P., Pronicki, M., Skiba, E., Werpachowska, I., Kaczmarski, M. (2011). Cytoker-
atin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Acta Biochimica 
Polonica, 58 (4). doi: http://doi.org/10.18388/abp.2011_2225 
[24] Vuppalanchi, R., Jain, A. K., Deppe, R., Yates, K., Comerford, M., Masuoka, H. C. et. al. (2014). Relationship Between 
Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcohol-
ic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 12 (12), 2121–2130.e2. doi: http://doi.org/10.1016/ 
j.cgh.2014.05.010 
[25] Vajro, P., Lenta, S., Socha, P., Dhawan, A., McKiernan, P., Baumann, U. et. al. (2012). Diagnosis of Nonalcoholic Fatty Liv-
er Disease in Children and Adolescents. Journal of Pediatric Gastroenterology and Nutrition, 54 (5), 700–713. doi: http:// 
doi.org/10.1097/mpg.0b013e318252a13f 
COMPARATIVE ASPECTS OF PLACENTAL DYSFUNCTION 
IN WOMEN USING DIFFERENT METHODS OF 
CONTRACEPTION IN ANAMNESIS
Oleksandra Lubkovska
Department of Obstetrics, Gynecology and Perinatology
Ukrainian State Institute of Reproductology
Shupyk National Medical Academy of Postgraduate Education
9 Dorohozhytska str., Kyiv, Ukraine, 04112
Abstract
The aim. To reduce the incidence of perinatal pathology in women who have used various methods of contraception, 
based on the study of the functional state of the fetoplacental complex (FPS), as well as improving diagnostic measures and tactics 
of pregnancy.
Materials and methods. 140 pregnant women were studied with their division into control and 3 test groups depending 
on the method of contraception in the anamnesis, using clinical, laboratory and instrumental research methods during pregnancy 
and childbirth.
Results. The study found that women with a history of intrauterine contraception (IUC), in contrast to combined oral 
contraception (COC) and combined oral contraception containing folate (COC+F), had a higher incidence of complications during 
pregnancy and childbirth, as well as fewer newborns with a satisfactory condition at birth. Assessment of folic acid levels at 6-8 
weeks of gestation showed significantly better results among women with a history of COC+F, compared with IUC and COC. In 
the group of women with IUC in the anamnesis, significantly worse mean endocrinological values prevailed, and there was also 
a greater number of pregnant women with disorders of fetal-placental blood flow. More pronounced dystrophic changes in the 
placentas of women in this group were pathomorphologically confirmed.
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Conclusions. The presence in the anamnesis of IUC is accompanied by a high proportion of pregnant women with various 
pathological conditions and is a risk factor for FPS dysfunction. The use of COC+F in the anamnesis is the best option for women 
of different risk groups.




Disturbance in the functioning of FPS leads to the formation of placental dysfunction (PD) 
and complications such as fetal distress, fetal growth restriction (FGR), increased perinatal mor-
bidity, etc., subsequently causing underdevelopment of the central nervous system, high inci-
dence in early and late neonatal periods and more [1, 2]. Among the potential causes of such 
violations, in addition to the generally accepted [3, 4], also highlight modern features in family 
planning, namely – the use of different methods of contraception. Despite the progress in its im-
provement [5, 6], including adding folate in the COC, because it is known that folate is involved 
in metabolic processes through nucleotide synthesis, DNA replication, which ensure cell division 
and growth [7, 8], the level of complication in the use of contraception remains significant and 
not fully studied from the standpoint of its impact on the functional state of FPS. Therefore, it is 
of interest to study the peculiarities of its functioning in women who used different methods of 
contraception before pregnancy.
The aim – to reduce the incidence of perinatal pathology in women who have used various 
methods of contraception, based on the study of the functional state of FPS, as well as improving 
diagnostic measures and tactics of pregnancy managment.
2. Materials and methods
The study was conducted from 2017 to 2019 on the basis of the Department of Obstetrics, 
Gynecology and Perinatology on the basis of the Kyiv Maternity Hospital No. 1, as well as Brovary 
Multidisciplinary Clinical Hospital. For the purpose of the study, 140 pregnant women were select-
ed and, depending on one or another method of contraception in the anamnesis, they were divided 
between groups and a control group was formed: Group I, or control – 35 women who did not use 
contraceptives before pregnancy; Group II – 35 women who had a history of COC use; Group III – 
35 women who took COC + F; Group IV – 35 women who used IUC.
The average age of the studied pregnant women in the intergroup comparison did not differ 
significantly. In the context of employment in all groups, working women predominated: from 
74.3 % in the control group to 85.7 % in group III. The vast majority of pregnant women in each 
group had higher education (from 74.3 % in group IV to 91.4 % in group III) and had a registered 
marriage, namely: 85.7 % in the control and IV groups, 91.4 % in the II and III ones. The age of 
onset of sexual life of the studied women also did not differ significantly, and most of them had no 
more than two sexual partners and were multipara. Young first-time-mothers were not included 
in the sample. The study involved women without severe ingenious and extragenital pathologies.
Assessment of FPS function and fetal status was performed on the basis of clinical, labora-
tory and instrumental studies during pregnancy and childbirth [9; 10]. Particular attention was paid 
to the additional inclusion in the diagnostic measures and tactics of pregnancy assessment of folic 
acid levels at 6–8 weeks and determination of the most informative endocrinological parameters 
(human chorionic gonadotropin (hcG), progesterone (P4), free estriol (uE3) and placental lactogen 
PL) with their different combination depending on the gestational age (6–8, 18–22, 30–32 and 
37–40 weeks of pregnancy). A pathomorphological examination of the placenta of women in labor 
with the determination of fetal/placental ratio (F/PR) in the postpartum period was also performed.
The study was conducted in accordance with the Declaration of Helsinki according to the 
conclusion of the Commission on Ethics of the National Medical Academy of Postgraduate Educa-
tion named after P.L. Shupyk (protocol No. 2 dated January 10, 2017). Informed consent to partic-
ipate in the study was obtained from all women.
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Statistical processing of the obtained data was performed using Statistica and Microsoft 
Office Excel. Evaluation of the statistical significance of the obtained data was performed using the 
Newman-Kayles and χ2 criteria. The differences were considered significant at p<0.05. 
3. Results 
The study of pregnancy revealed some differences in the functional state of FPS depending 
on the method of contraception in the anamnesis. Thus, the analysis of the first half of pregnancy 
showed that in group III, in which women used COC+F, women with threatened abortion were 
absent, which is significantly lower than in the control, II and IV groups, while IUC in the history 
resulted in more women with not only threatened abortion but also bacterial vaginosis (BV) com-
pared to other groups (Table 1).
Table 1
Peculiarities of pregnancy in the studied women
Indicators
Groups of women







% (abs.) % (abs.) % (abs.) % (abs.)
The first half of pregnancy
Threatened abortion 11.4 (4) 11.4 (4) – 31.4 (11) рІІ-К>0.05; pІІІ-К<0.05; pІV-К<0.05; pІІ-ІІІ<0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01
Bacterial vaginosis – 2.9 (1) 2.9 (1) 17.1 (6) pІІ-К>0.05; pІІІ-К>0.05; pІV-К<0.01; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05
The second half of pregnancy
Threat of premature birth 8.6 (3) 5.7 (2) 5.7 (2) 28.6 (10) pІІ-К>0.05; pІІІ-К>0.05; pІV-К<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05
Low-lying placenta 2.9 (1) 2.9 (1) – 17.1 (6) pІІ-К>0.05; pІІІ-К>0.05; pІV-К<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01
Placental dysfunction 17.1 (6) 17.1 (6) 2.9 (1) 40 (14) pІІ-К>0.05; pІІІ-К<0.05; pІV-К<0.05; pІІ-ІІІ<0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01
Fetal growth restriction 2.9 (1) 2.9 (1) – 17.1 (6) pІІ-К>0.05; pІІІ-К>0.05; pІV-К<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01
The second half of pregnancy was also accompanied in some pregnant women by the corre-
sponding complications, among which most often, as can be seen from table 1, there was placental 
dysfunction and the threat of premature birth. The results showed that taking in anamnesis COC 
and COC+F is quite positive for a normal pregnancy, in contrast to the IUC. However, given the 
number of women with PD, the use of COC+F was significantly better compared not only with the 
use of IUC, but also with COC.
In addition, the course of pregnancy was marked by the occurrence of other complications, 
including early toxicosis, fetal distress, mild anemia, cervical insufficiency (CI), placental abrup-
tion, polyhydramnios and dehydration. However, their frequency was low and the differences be-
tween the groups were insignificant.
The clinical course of childbirth was characterized by premature rupture of membranes 
(PROM) (control group – 2.9 % (i. e. in one woman), II – 0 % (there were no cases), III – 2.9 % (in 
one woman), IV – 17.1 % (in six women); рІІ-C>0.05, pІІІ-C>0.05, pІV-C<0.05, pІІ-ІІІ>0.05, pІІ-ІV<0.01, 
pІІІ-ІV<0.05), anomalies of labor (control group – 2.9 % (in one woman), II – 2.9 % (in one woman), 
III – 2.9 % (in one woman), IV – 17.1 % (in six women); pІІ-C>0.05, pІІ-C>0.05, pІV-C<0.05, pІІ-ІІІ>0.05, 
pІІ-ІV<0.05, pІІІ-ІV<0.05), fetal distress during childbirth (control group – 2.9 % (in one woman), II – 
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2.9 % (in one woman), III – 0 % (there were no cases), IV – 11.4 % (in four women); pІІІ-ІV<0.05). 
The significance of the differences between IV and other groups indicates a less favorable effect of 
the use of IUC in the anamnesis, in contrast to the use of COC, COC+F and the general non-use of 
any of these methods of contraception.
After birth, almost all newborns had a satisfactory condition: at the level of 100 % (i. e. 35 
newborns) in group III, 97.1 % (34 newborns) in the control and II groups, as well as 82.9 % (29 
newborns) in group IV, which is significantly lower than these indicators (pІІ-C>0.05; pІІІ-C>0.05; 
pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01). In addition, in the group in which pregnant women 
used IUC, 14.3 % (i.e., five newborns) had mild asphyxia, and 2.9 % (one newborn) had moderate 
asphyxia.
In the process of deeper study of the functional state of FPS, the following results were 
obtained. During 6–8 weeks of pregnancy, the average level of folic acid saturation was highest 
in group III and was 16.1±1.8 ng/ml, which differed significantly from that in the control group, 
in which it was at the level of 9.5±0.9 ng/ml, in group II – 9.2±1.3 ng/ml and in group IV – 9.4±1.2 
ng/ml (pІІ-C>0.05; pІІІ-C<0.01; pІV-C>0.05; pІ-ІІІ<0.01; pІІ-ІV>0.05; pІІІ-ІV<0.01). HcG was character-
ized by statistically significantly higher in group III (164992.4±5896.3 mlU/ml) and significantly 
lower in group IV (116568.8±11538.8 mlU/ml) average levels, compared with the control group – 
141017±5440, 3 mlU/ml – and group II – 139758.6±5566.1 mlU/ml (pІІ-C>0.05; pІІІ-C<0.01; pІV-C<0.01; 
pІІ-ІІІ<0.01; pІІ-ІV<0.01; pІІІ-ІV<0.01). A similar picture developed with respect to P4: significantly the 
highest average level in group III (69.9±4.5 ng/ml), and the lowest – in group IV (42.5±4.1 ng/ml) 
(pІІ-C>0.05; pІІІ-C<0.01; pІV-C<0.01; pІІ-ІІІ<0.01; pІІ-ІV<0.01; pІІІ-ІV<0.01).
The study of endocrinological parameters at 18–22 weeks of pregnancy, namely hcG, P4, 
uE3 and PL as characteristic of this gestational age, revealed the following trends. The maximum 
mean value of hcG was in group III (37074.3±3182.4 mlU/ml), and the minimum – in group IV 
(30467.9±2054.6 mlU/ml), with statistical significance (p<0.05) differences between IV and other 
groups. The highest mean P4 was recorded in group III (82.7±2.4 ng/ml), and the lowest – in group 
IV (69.7±3.9 ng/ml) (pІІ-C>0.05; pІІІ-C<0.05; pІV-C<0.05; pІІ-ІІІ<0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01). The av-
erage values of uE3 were in the control group at the level of 5.4±0.5 ng/ml, in II – 5.1±0.4 ng/ml, 
in III – 5.7±0.3 ng/ml, in IV group – 4.5±0.4 ng/ml (significantly the lowest rate) (pІІ-C>0.05; 
pІІІ-C>0.05; pІV-C<0.01; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01). 
The maximum mean value of PL occurred in group IV (4.7±0.5 mg/L), in particular because 
there was an excess of the norm in 17.1 % of pregnant women, i.e. in six women in this group, at 
2.9 % (one) of pregnant women with this disorder in group II (pІІ-C>0.05; pІІІ-C>0.05; pІV-C<0.01; 
pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.01). The minimum mean value of PL was in the control (3.5±0.2 
mg/L), while in group II the index was on average at 3.8±0.3 mg/L, and in group III – at level 3.6± 
±0.1 mg/L, with significant differences between IV and other groups (pІІ-C>0.05; pІІІ-C>0.05; 
pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05).
The use of ultrasound examination (UE) at 18–22 weeks of pregnancy made it possible to 
clinically detect in group IV a significantly higher frequency of FPS dysfunction, such as: prema-
ture maturation of the placenta and Low-lying placenta. There was also marginal placenta previa 
and placental hyperplasia, but their frequency was low and the differences between the groups 
were insignificant.
During 30-32 weeks of pregnancy, the average values of these endocrinological parameters 
had a similar trend. HcG in group III was significantly the highest (33977.6±1300.8 mlU/ml), and 
in IV – the lowest (30143.4±1489.3 mlU/ml); pІІ- C>0.05; pІІІ- C<0.05; pІV-C>0.05; pІІ-ІІІ<0.01; pІІ-ІV>0.05; 
pІІІ-ІV<0.01). The use of COC+F led to an increase in the mean value of P4, then the IUC – to a cer-
tain decrease (pІІ-C>0.05; pІІІ-C<0.01; pІV-C<0.05; pІІ-ІІІ<0.01; pІІ-ІV<0.05; pІІІ-ІV<0.01). Regarding uE3, 
in group IV there was a decrease in its average value, compared with other groups (pІІ-C>0.05; 
pІІІ-C>0.05; pІV-C<0.01; pІ-ІІІ>0.05; pІІ-ІV<0.01; pІІІ-ІV<0.01).
Regarding PL, it should be noted that its average values in the analyzed groups did not differ 
significantly, in contrast to the number of pregnant women in whom it was recorded exceeding 
or decreasing below normal. Thus, in the control group was recorded 8.6 % of pregnant women 
(i. e. three) with the value of this indicator above normal, in group II – 5.7 % (two) pregnant women 
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above normal and 2.9 % (one) women below norms; in group III – no deviations from the norm; 
in group IV – 20 % (seven) of pregnant women above normal and 5.7 % (two) of women below 
normal, which is statistically significant (pІІ-C>0.05; pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; 
pІІІ-ІV<0.01). 
UE at this time of pregnancy showed the highest number of complications in the group 
with a history of IUC, and the lowest - with COC+F, there were significant differences between 
IV and other groups regarding premature placental maturation (5.7 % (two)) of pregnant women in 
the control and II groups, in 2.9 % (in one) women in group III and in 22.9 % (in eight) persons in 
group IV; pІІ-C>0.05; pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05).
Doppler results showed impaired blood flow in the umbilical artery in 5.7 % (two) of preg-
nant women from the control, 2.9 % (one) from group II and 8.6 % (three) women from group IV. 
There were no such violations in group III. Also in all groups there were no disturbances of a blood 
flow in a middle cerebral artery of a fetus. Cardiotocogram (CTG) and biophysical profile (BP) 
were within normal limits.
Endocrinological parameters (P4, uE3, PL) at 37–40 weeks showed the best mean values 
in the group in which women before pregnancy used COC+F (in particular in the part of uE3 
significantly higher than the control and a group with a history of COC), and significantly worse 
results – in the group in which they used IUC, compared with other groups.
At UE in this period of pregnancy the presence of such complications as: placental hyper-
plasia in the control and II groups – 2.9 % (in one pregnant woman in each group), in III – 0 % 
(there were no cases), in IV – 6.1 % (in two) and placental hypoplasia (3.0 % (in one) in group IV), 
polyhydramnios (2.9 % (in one) in group III and 6.1 % (in two) in group IV) , dehydration (in con-
trol and II groups – 2.9 % (one pregnant woman), in III – 0 % (cases were absent), in IV – 9.1 % (in 
three), as well as FGR (in control and II groups – 2.9 % (in one pregnant woman in each group), 
in III – 0 % (there were no cases), in IV – 12.1 (in four) %; RIII-IV<0.05). By the time of the exam-
ination, one woman in the control group and two in the IV group had premature births.
Doppler showed that the pulsation index (IP) of the umbilical artery at 37–40 weeks 
of pregnancy was in the control group on average at 0.90±0.07, in group II – 0.89±0.06, in 
group III – 0.87±0.05, in group IV – 1.01±0.09 (pІІ-C>0.05; pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; 
pІІ-ІV<0.05; pІІІ-ІV<0.05); IP of the middle cerebral artery of the fetus – at the level of 1.73±0.01 in 
the control, 1.72±0.01 in group II, 1.75±0.02 in group III and 1.56±0.03 in group IV (pІІ-C>0.05; 
pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05).
The gestational age of 37–40 weeks was marked by a CTG score of 8–10 on the Fisher scale 
in 97.1 % in the control and II groups (i. e. in 33 and 34 pregnant women, respectively), in 100 % (in 
35 pregnant women) – in group III and in 81.8 % (in 27 pregnant women) – in group IV (pІІ-C>0.05; 
pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; pІІ-ІV<0.05; pІІІ-ІV<0.05). Determination of BP in this period showed 
in most pregnant women a satisfactory fetal condition (7–10 points): 100 % in the control (i. e. 34 
pregnant women), 97.1 % (34 pregnant women) in the II, 100 % in 35 pregnant women) in group 
III and 87.9 % (in 29 pregnant women) in group IV (pІІ-C>0.05; pІІІ-C>0.05; pІV-C<0.05; pІІ-ІІІ>0.05; 
pІІ-ІV>0.05; pІІІ-ІV<0.05).
A pathomorphological examination of the placenta of women in labor with the determina-
tion of F/PR was also performed. Its mean value was 0.14±0.007 in the control group, 0.15±0.009 
in group II, 0.14±0.006 in group III and 0.17±0.011 in group IV (maximum) (pІІ-C>0.05; pІІІ-C>0.05; 
pІV-C<0.01; pІІ-ІІІ>0.05; pІ-ІV<0.01; pІІІ-ІV<0.01).
In addition, it was macroscopically determined that in the control, II and III groups, most 
placentas had a normal structure. Microscopic examination of these groups revealed minor involu-
tive-dystrophic changes in most placentas, compared with placentas of women with FPS disorders, 
in whom the changes were more pronounced. In patients who were in group IV and who had PD 
during pregnancy, the placenta was characterized by the most pronounced dystrophic changes.
4. Discussion
The normal state of FPS plays a key role in the normal course of pregnancy and childbirth, 
as well as in ensuring satisfactory fetal development. Based on the data of modern literature, the 
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key symptom complex that reflects the deviation from the normal functioning of FPS is PD, which 
may be accompanied by polyhydramnios, hypohydramnios, FGR, fetal distress, etc. [11, 12]. In 
addition, during pregnancy, complications such as threatened abortion, early toxicosis, BV, the 
threat of premature birth, anemia, CI and others may occur [13, 14]. As a result, it can adversely 
affect the condition of the newborn. Therefore, studying the functioning of FPS in women using 
different methods of contraception in the anamnesis, the main attention was paid to the relevant 
disorders that occur in it.
In the process of family planning, one of the key links is contraception, the choice of meth-
ods which depends on age, health status, the relationship between partners, and so on. However, 
according to recent data, the most common, if we do not take into account barriers, are COC and 
IUC [15, 16]. COC+F has also been gaining popularity recently. This is due to the fact that folic 
acid deficiency during pregnancy, especially in the first weeks, leads to impaired chorionic cell 
proliferation and placental formation, which subsequently manifests itself in the occurrence of PD 
and FGR, as well as increases the likelihood of miscarriage, in including the threat of premature 
birth [17, 18].
In this context, the results of the study confirmed the advantage of using a method of con-
traception such as COC+F, compared with the use of IUC, and in some respects – and take of COC.
Also one of the common factors of PD is inflammatory processes of the pelvic organs. In turn, 
the literature data indicate the frequent cause of such inflammatory processes using IUC [19, 20]. 
The results obtained by us are consistent with the following data.
Thus, the study made it possible to identify new aspects of the pathogenesis of disorders of 
the functional state of FPS, as well as to determine the most optimal method of contraception and 
one that acts as a risk factor for these disorders.
Study limitations. The study did not include women with severe genital and extragenital 
pathologies, young first-time-mothers, and women who refused to participate in the study.
Prospects for further research. Study of the features of folate metabolism in women who 
have used various methods of contraception, in order to increase the effectiveness of pre-pregnancy 
training of such women in terms of correction of folic acid levels.
5. Conclusions
The results obtained during the study provided an opportunity to identify new aspects of 
the pathogenesis of functional disorders of FPS, which take into account the use in the history of 
various methods of contraception. In particular, a decrease in folic acid levels in pregnant women 
below normal at 6–8 weeks is accompanied by the subsequent occurrence of threatened abortion 
and the development of PD. In addition, placental hormonal dysfunction, namely hcG, P4, uE3, and 
PL synthesis, that occurs at different stages of gestation, especially in women with a history of IUC, 
is a preclinical manifestation of PD and related complications.
Also, a study of the clinical course of pregnancy and childbirth showed that women with 
a history of IUC, compared with COC and COC+F, had a higher incidence of complications and 
fewer newborns with a satisfactory condition at birth (82.9 % vs. 97.1 % and 100 % respectively).
This made it possible to determine the presence of a history of IUC as a risk factor for 
functional disorders of FPS, namely the occurrence of PD, as confirmed by pathomorphological 
studies, and the use of a history of COC+F is the best option for women of different risk groups. 
complications and prevent functional disorders of FPS.
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